Among the companies with shares expected to actively trade in
Friday's session are Vanda Pharmaceuticals Inc. (VNDA),
Kimberly-Clark Corp. (KMB) and Cell Therapeutics Inc. (CTIC).
Vanda said a U.S. Food and Drug Administration advisory
committee voted to approve the company's flagship drug,
tasimelteon, a potential treatment for Non-24-Hour Disorder.
Tasimelteon, which has the proposed tradename Hetlioz, is currently
under priority review by the FDA, which will make a final decision
on approving the drug in January. Vanda's shares jumped 13% to
$14.73 in premarket trading.
Kimberly-Clark is mulling a spinoff of its health-care business,
potentially unloading a division that generates about $1.6 billion
in annual sales but represents the consumer-products giant's
smallest business. Investors cheered the news, sending shares up 3%
to $113 in premarket trading.
Baxter International Inc. (BAX) and Cell Therapeutics Inc.
(CTIC) unveiled an exclusive licensing agreement to develop and
commercialize pacritinib, which is currently in Phase III
development to treat a chronic bone marrow disorder. Shares climbed
21% to $2.12 premarket.
T-Mobile US Inc.'s (TMUS) offering of about 66.2 million shares
priced at a 2% discount to the wireless carrier's closing price.
The offering priced at $25 a share and is expected to generate
about $1.6 billion in proceeds, T-Mobile disclosed late Thursday.
Shares were off 2.5% at $24.89 premarket.
Watch List:
Agilent Technologies Inc.'s (A) fiscal fourth-quarter earnings
fell 50% as continued weakness in its electronic measurement
business that the company is in the process of spinning off
continued to weigh on the diversified testing-equipment maker's
revenue. The company's adjusted profit topped expectations.
Applied Materials Inc. (AMAT) swung to fiscal fourth-quarter
profit on double-digit revenue growth and stronger margins. The
company, which supplies costly machines that help turn silicon
wafers into computer chips, also gave a mostly cautious outlook for
the current quarter.
Jos. A. Bank Clothiers Inc. (JOSB) terminated its unsolicited
$2.3 billion takeover offer for rival men's clothing retailer Men's
Wearhouse Inc. (MW), though left the door open for the potential of
future acquisition talks.
Activist investor Carl Icahn reported an increased holding in
Navistar International Corp. (NAV) as of Sept. 30, according to a
regulatory filing Thursday.
Nordstrom Inc.'s (JWN) fiscal third-quarter profit slid 6.2% as
the high-end retailer's sales growth was tempered by the absence of
a key sale event that was held earlier in the year, while overhead
expenses jumped.
Write to Nathalie Tadena at nathalie.tadena@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires